Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
Mylan announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for Cabergoline Tablets.
Sanofi announced full results for EDITION II (basal insulin + oral therapy) and additional results from its EDITION Phase 3 program for EDITION III, EDITION IV, and EDITION JP I for the investigational new insulin U300 in patients with type 1 or type 2 diabetes.
Racial differences in both processes of care and intermediate outcomes for patients with diabetes were observed.
Risk of incident diabetes, cardiovascular disease also up for metabolically unhealthy normal weight.
According to recent research, many cases of corticotropin-independent macronodular adrenal hyperplasia appear to result from two copies of a mutant gene.
This activity will teach how to lower cholesterol through diet, lifestyle changes, and medication. This activity is accredited ...1.00 CE for Nurses
An emerging class of antidiabetes drugs targets renal glucose transporters. To help clinicians understand the rationale behind and ...2.00 AMA PRA Category 1 Credit(s)TM
Recognizing the possible consequences of unmanaged hyponatremia in heart failure patients and implementing appropriate treatment strategies are critical ...1.50 AMA PRA Category 1 Credit(s)TM